Published in Gene Ther on March 01, 2006
Stem cells in human neurodegenerative disorders--time for clinical translation? J Clin Invest (2010) 3.62
GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One (2007) 1.99
Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One (2007) 1.38
Treatment of Parkinson's disease with trophic factors. Neurotherapeutics (2008) 1.35
Cell therapeutics in Parkinson's disease. Neurotherapeutics (2011) 1.32
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res (2009) 1.20
Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS One (2009) 1.15
Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp Neurol (2008) 1.08
Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform. Neurosurgery (2009) 1.06
Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant (2008) 1.05
Stem cell therapy for the spinal cord. Stem Cell Res Ther (2012) 1.05
Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? Regen Med (2011) 1.03
Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review. J Adv Res (2013) 0.88
Labeling of neuronal differentiation and neuron cells with biocompatible fluorescent nanodiamonds. Sci Rep (2014) 0.86
Cell-based therapies for Parkinson's disease: past, present, and future. Antioxid Redox Signal (2009) 0.85
Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. PLoS One (2010) 0.85
Conditional Sox9 ablation reduces chondroitin sulfate proteoglycan levels and improves motor function following spinal cord injury. Glia (2012) 0.84
Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives. Stem Cell Res Ther (2014) 0.84
Gene and stem cell therapy: alone or in combination? Bioimpacts (2011) 0.83
New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies. Cell Tissue Res (2012) 0.82
Regenerative cellular therapies for neurologic diseases. Brain Res (2015) 0.82
Preclinical assessment of stem cell therapies for neurological diseases. ILAR J (2009) 0.81
Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase. J Neurosci Methods (2008) 0.81
Recent advances of stem cell therapy for retinitis pigmentosa. Int J Mol Sci (2014) 0.81
In vivo tracking of human neural progenitor cells in the rat brain using bioluminescence imaging. J Neurosci Methods (2014) 0.81
Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease. J Cell Mol Med (2012) 0.80
In Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression. Cell Transplant (2015) 0.79
Regulated expression of lentivirus-mediated GDNF in human bone marrow-derived mesenchymal stem cells and its neuroprotection on dopaminergic cells in vitro. PLoS One (2013) 0.79
Efficient transduction of feline neural progenitor cells for delivery of glial cell line-derived neurotrophic factor using a feline immunodeficiency virus-based lentiviral construct. J Ophthalmol (2010) 0.77
Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys. Sci Rep (2013) 0.77
Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties. Fluids Barriers CNS (2015) 0.77
A Subsequent Human Neural Progenitor Transplant into the Degenerate Retina Does Not Compromise Initial Graft Survival or Therapeutic Efficacy. Transl Vis Sci Technol (2015) 0.76
Feline neural progenitor cells II: use of novel plasmid vector and hybrid promoter to drive expression of glial cell line-derived neurotrophic factor transgene. Stem Cells Int (2012) 0.75
Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo. Gene Ther (2016) 0.75
Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease. BMC Neurosci (2016) 0.75
Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1(G93A) ALS rat but has adverse side effects. Gene Ther (2017) 0.75
Lost highway(s): barriers to postnatal cortical neurogenesis and implications for brain repair. Front Cell Neurosci (2015) 0.75
A transposon-mediated system for flexible control of transgene expression in stem and progenitor-derived lineages. Stem Cell Reports (2015) 0.75
The nucleic acid database. A comprehensive relational database of three-dimensional structures of nucleic acids. Biophys J (1992) 21.67
A role for CD95 ligand in preventing graft rejection. Nature (1995) 6.07
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia (2005) 5.47
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol (1995) 5.43
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol (1996) 4.99
Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron (1999) 4.22
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia (2003) 4.17
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (2000) 3.89
The PDB data uniformity project. Nucleic Acids Res (2001) 3.65
CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J Virol (1998) 3.60
Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect (1996) 3.34
Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population. BMJ (1991) 3.30
Long-term treatment of pulmonary hypertension with aerosolized iloprost. Eur Respir J (2001) 3.27
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med (2000) 2.86
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci U S A (2002) 2.81
Direct detection of HIV RNA expression in seropositive subjects. Lancet (1988) 2.75
Infectious complications of subcutaneous interleukin-2 and interferon-alpha. Lancet (1992) 2.65
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther (2009) 2.60
Molecular diagnosis of infective endocarditis--a new Duke's criterion. Scand J Infect Dis (2001) 2.36
Current status of ketamine anaesthesia. Lancet (1971) 2.28
Gene cluster for streptomycin biosynthesis in Streptomyces griseus: nucleotide sequence of three genes and analysis of transcriptional activity. Nucleic Acids Res (1987) 2.28
Which gp160 vaccine? Nature (1993) 2.27
A new method for radionuclide imaging of myocardial infarcts. Radiology (1974) 2.24
Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi. Ann Intern Med (1998) 2.22
Early prediction of individual outcome after cardiopulmonary resuscitation. Lancet (1993) 2.21
The methionine chain elongation pathway in the biosynthesis of glucosinolates in Eruca sativa (Brassicaceae). Arch Biochem Biophys (2000) 2.15
Certification, accreditation, and quality control in behavior analysis. Behav Anal (2001) 2.14
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology (2008) 2.13
Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia. Anesthesiology (1998) 2.09
Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluation. Endoscopy (2001) 2.07
Oxybenzone oxidation following solar irradiation of skin: photoprotection versus antioxidant inactivation. J Invest Dermatol (1996) 2.07
Presence or absence of gas in the appendix: additional criteria to rule out or confirm acute appendicitis--evaluation with US. Radiology (2000) 2.05
Laryngeal mask airway for caesarean section. Anaesthesia (1990) 2.05
Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol (2000) 2.03
Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science (1989) 2.03
Some historical and conceptual relations among logical positivism, operationism, and behaviorism. Behav Anal (1985) 1.99
The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations. Intensive Care Med (1996) 1.98
Pumilio is essential for function but not for distribution of the Drosophila abdominal determinant Nanos. Genes Dev (1992) 1.85
Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol (1992) 1.82
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol (1999) 1.82
Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther (2000) 1.81
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72
Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol (2001) 1.70
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer (2004) 1.70
A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol (1995) 1.70
A d.c. magnetic metamaterial. Nat Mater (2008) 1.69
Structure and function of a periplasmic nitrate reductase in Alcaligenes eutrophus H16. J Bacteriol (1993) 1.69
Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem (1992) 1.69
Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs. Environ Health Perspect (1999) 1.66
Evaluation of midazolam as an intravenous induction agent. Anaesthesia (1981) 1.64
Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant (2007) 1.63
Comparative genome analysis of "Candidatus Phytoplasma australiense" (subgroup tuf-Australia I; rp-A) and "Ca. Phytoplasma asteris" Strains OY-M and AY-WB. J Bacteriol (2008) 1.62
Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci (1995) 1.61
Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.61
Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther (2000) 1.60
General practitioners' and patients' models of obesity: whose problem is it? Patient Educ Couns (2001) 1.59
In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc (1999) 1.58
Characterization of the ets oncogene family member, fli-1. J Biol Chem (1993) 1.57
Subsistence strategies of two "savanna" chimpanzee populations: the stable isotope evidence. Am J Primatol (1999) 1.57
A chink in HIV's armour? Nature (1990) 1.56
Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol (1999) 1.56
Outer diameter of the vermiform appendix as a sign of acute appendicitis: evaluation at US. Radiology (2001) 1.56
Ketamine as an induction agent in anaesthetics. Lancet (1970) 1.55
Molecular mapping of QTLs for Fusarium head blight resistance in spring wheat. II. Resistance to fungal penetration and spread. Theor Appl Genet (2003) 1.55
Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol (2000) 1.54
Evaluation of risk factors for stroke/embolism and of complications due to anticoagulant therapy in atrial fibrillation. Stroke (2001) 1.54
Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease. Endoscopy (1998) 1.53
The role of ferritin and hemosiderin in the MR appearance of cerebral hemorrhage: a histopathologic biochemical study in rats. AJNR Am J Neuroradiol (1990) 1.53
Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci (1997) 1.52
The MLL recombinome of acute leukemias. Leukemia (2006) 1.51
BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol (2001) 1.51
Phylogenetic classification of phytopathogenic mollicutes by sequence analysis of 16S ribosomal DNA. Int J Syst Bacteriol (1994) 1.50
Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood (1993) 1.50
Activation of CD95L fusion protein prodrugs by tumor-associated proteases. Cell Death Differ (2006) 1.50
Hydrogen Concentration Profiles at the Oxic-Anoxic Interface: a Microsensor Study of the Hindgut of the Wood-Feeding Lower Termite Reticulitermes flavipes (Kollar). Appl Environ Microbiol (1997) 1.50
Choice and number of reinforcers. J Exp Anal Behav (1979) 1.49
A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*). Endoscopy (2003) 1.48
Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J Neurosci (2001) 1.48
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A (2001) 1.47
Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders. Lancet (1987) 1.47
Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol (1999) 1.46
A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis (2004) 1.46
The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. Eur J Gastroenterol Hepatol (1999) 1.45
Bioinformatics construction of the human cell surfaceome. Proc Natl Acad Sci U S A (2009) 1.45
Retroperitoneal lymphangiectasia associated with bilateral renal vein thrombosis. Nephrol Dial Transplant (1997) 1.45
Detection of nontraumatic comatose patients with no benefit of intensive care treatment by recording of sensory evoked potentials. Arch Neurol (1996) 1.45
Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol (2000) 1.42
Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.42
A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum Gene Ther (1997) 1.42
On privacy, causes, and contingencies. Behav Anal (1984) 1.42
Cesarean delivery in a patient with a transplanted heart. Anesthesiology (1989) 1.41
Women, violence, and HIV: a critical evaluation with implications for HIV services. Matern Child Health J (2000) 1.41
Effect of cold submersion on intramuscular temperature of the gastrocnemius muscle. Phys Ther (1979) 1.40
Paramedic field instructors: an approach to training the newest paramedics while maintaining the interest of the most successful senior paramedics. Prehosp Disaster Med (1995) 1.40
Treatment of diseases of the central nervous system using encapsulated cells. Adv Tech Stand Neurosurg (1999) 1.39
Equivalent discrimination among states of thyroid function by immunochemiluminimetric and immunoradiometric determination of thyrotropin. Clin Chem (1993) 1.39